Pharmalink


     Molecule     Brands     Company

Login Login

Recent KFDA Approval& NHI enlisting

  • Product Search
  • Recent KFDA Approval& NHI enlisting
From ~ To

Date : ~
KFDA Approval
NHI enlisting
ShapeDatePackBrandsFormCompanyCompositionETCDocu.
Requi.		Regul.
Status		BEPVProd.
Status		Equiv.
Product		Contact
2014.03.01Urogen tab.ATRDongkoo Bioalfuzosin HCl 10mgETCIORMKTOIORIOR
2014.03.01Urodin tab. 4mgATRDongkoo Biotolterodine L-tartrate 4mgETCIORMKTOIORIOR
2014.03.01Uropa tab. 0.2mgATRDongkoo Biotamsulosin HCl 200ugETCIORMKTOIORONP
 2014.03.01Upatarin tab.ATBDongkoo Bioartemisiae argyi folium 95% ethanol fluid ext.(20:1) 60mgETCIORAPPIORIOR
2014.03.01Xansiq tab.ATBDongkoo Bioranitidine HCl 150mgETCIORMKTOIORONP
 2014.03.01Futhan inj.BIJSK Chemicalsnafamostat mesylate 10mgETCIORMKTIORONP
 2014.03.01Jimuradol tab.ATBDongkoo Bioacetaminophen 325mg and 1 othersETCIORMKTOIORIOR
 2014.03.01Ginkoid-S tab.ATBDongkoo Bioginkgo biloba leaf ext. 80mgOTCIORMKTIORONP
2014.03.01Kanarb tab. 120mgATBBoryung Pharmfimasartan potassium trihydrate 132.02mgETCIORAPPOIORIOR
2014.03.01Cardiren tab. 25mgATBDongkoo Biocarvedilol 25mgETCIORMKTOIORONP
2014.03.01Carizin tab. 500mgATBTaejoon Pharmbendazac lysine 500mgETCIORMKTIORONP
 2014.03.01Cefaclor r&p cap. 250mgRP BioIORAPPIOR
 2014.03.01R&p atenolol tab. 50mgRP BioIORAPPIOR
 2014.03.01Barobon-F soft cap.RP BioIORAPPIOR
 2014.03.01DermastopDongkoo Bio
 2014.03.01Dermota sone lotionCLTDongkoo Biomometasone furoate 1mgETCIORMKTIORIOR
2014.03.01Famclovir tab. 250mgATBDongkoo Biofamciclovir 250mgETCIORMKTOIORONP
 2014.03.01Fexophen tab. 120mgATBDongkoo Biofexofenadine HCl 120mgOTCIORAPPOIORIOR
 2014.03.01Prozosin tab. 2mgATBDongkoo Bioterazosin HCl 2mgETCIORMKTOIORONP
 2014.03.01Pumatifen tab. 1mgATBDongkoo Bioketotifen fumarate 1.38mgETCIORMKTOIORONP
◁ ◀ 21  22  23  24  25  26  27  28  29  30 ▶ ▷
PharmaLink.kr  |  Jin BD 2nd floor, Sadangdong 1039-59, Dongjak-Gu, Seoul
E-Mail : pharmabase@nate.com    Tel : 82-70-7815-2200
Copyright ⓒ2013~2016 PharmaLink.Kr   ALL RIGHTS RESERVED.